Famciclovir or valaciclovir in the management of herpes simplex and varicella zoster infections: an attitudinal survey of clinician perceptions of differential activity
Don E. Smith A B and Julian Gold A
+ Author Affiliations
- Author Affiliations
A Albion Street Centre, Sydney, NSW 2000, Australia.
B Corresponding author. Email: Don.Smith@sesiahs.health.nsw.gov.au
Sexual Health 4(2) 141-142 https://doi.org/10.1071/SH06060
Submitted: 20 October 2006 Accepted: 23 April 2007 Published: 23 May 2007
References
[1] Fleming DT, McQuillan GM, Johnson RE, Nahmias AJ, Aral SO, Lee FK, et al. Herpes simplex virus type 2 in the United States, 1976–1994. N Engl J Med 1997; 337 1105–11.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[2] Jumaan AO, Yu O, Jackson LA, Bohlke K, Galil K, Seward JF. Incidence of herpes zoster, before and after varicella-vaccination-associated decreases in the incidence of varicella, 1992–2002. J Infect Dis 2005; 191 2002–7.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[3] Beutner KR, Friedman DJ, Forszpaniak C, Andersen PL, Wood MJ. Valaciclovir compared with acyclovir for improved therapy for herpes zoster in immunocompetent adults. Antimicrob Agents Chemother 1995; 39 1546–53.
| PubMed |
[4] Chosidow O, Drouault Y, Leconte-Veyriac F, Aymard M, Ortonne JP, Pouget F, et al. Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial. Br J Dermatol 2001; 144 818–24.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[5] Fife KH, Barbarash RA, Rudolph T, Degregorio B, Roth R. Valaciclovir versus acyclovir in the treatment of first-episode genital herpes infection. Results of an international, multicenter, double-blind, randomized clinical trial. The Valaciclovir International Herpes Simplex Virus Study Group. Sex Transm Dis 1997; 24 481–6.
| Crossref | GoogleScholarGoogle Scholar | PubMed |
[6] Tyring S, Barbarash RA, Nahlik JE, Cunningham A, Marley J, Heng M, et al. Famciclovir for the treatment of acute herpes zoster: effects on acute disease and postherpetic neuralgia. A randomized, double-blind, placebo-controlled trial. Collaborative Famciclovir Herpes Zoster Study Group. Ann Intern Med 1995; 123 89–96.
| PubMed |
[7] Mertz GJ, Loveless MO, Levin MJ, Kraus SJ, Fowler SL, Goade D, et al. Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women. A multicenter, double-blind, placebo-controlled trial. Collaborative Famciclovir Genital Herpes Research Group. Arch Intern Med 1997; 157 343–9.
| Crossref | GoogleScholarGoogle Scholar | PubMed |